These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2314480)

  • 1. NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine.
    Mülsch A; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):143-7. PubMed ID: 2314480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NG-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart.
    Lamontagne D; Pohl U; Busse R
    Pflugers Arch; 1991 Apr; 418(3):266-70. PubMed ID: 1649992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery.
    Vo PA; Reid JJ; Rand MJ
    Br J Pharmacol; 1992 Dec; 107(4):1121-8. PubMed ID: 1467834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and a calcium-independent mechanism.
    Mülsch A; Bassenge E; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):767-70. PubMed ID: 2576763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The L-arginine-nitric oxide pathway in the canine femoral vascular bed: in vitro and in vivo experiments.
    Richard V; Gosgnach M; Drieu la Rochelle C; Giudicelli JF; Berdeaux A
    Fundam Clin Pharmacol; 1991; 5(9):777-88. PubMed ID: 1794833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
    Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
    Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
    Hecker M; Mitchell JA; Harris HJ; Katsura M; Thiemermann C; Vane JR
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1037-43. PubMed ID: 2322257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium-dependent relaxation to acetylcholine in bovine oviductal arteries: mediation by nitric oxide and changes in apamin-sensitive K+ conductance.
    García-Pascual A; Labadía A; Jimenez E; Costa G
    Br J Pharmacol; 1995 Aug; 115(7):1221-30. PubMed ID: 7582549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
    Moore PK; al-Swayeh OA; Chong NW; Evans RA; Gibson A
    Br J Pharmacol; 1990 Feb; 99(2):408-12. PubMed ID: 2328404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.
    Rees DD; Palmer RM; Hodson HF; Moncada S
    Br J Pharmacol; 1989 Feb; 96(2):418-24. PubMed ID: 2924084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery.
    Cosentino F; Sill JC; Katusić ZS
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H413-8. PubMed ID: 8383455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
    Crack P; Cocks T
    Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and ex vivo inhibitory effects of L- and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta.
    Wang YX; Poon CI; Pang CC
    J Pharmacol Exp Ther; 1993 Apr; 265(1):112-9. PubMed ID: 8473999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
    Zembowicz A; Hatchett RJ; Jakubowski AM; Gryglewski RJ
    Br J Pharmacol; 1993 Sep; 110(1):151-8. PubMed ID: 7693274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the endothelium and cyclic GMP in renal vasodilator responses to cryptolepine in rats.
    Oyekan AO
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):602-11. PubMed ID: 7516010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of LP-805, a releaser of endothelium-derived nitric oxide, on systemic vasodilatation in vivo.
    Inazu M; Tujitani M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):178-83. PubMed ID: 8232597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent dilation to L-arginine in isolated rat skeletal muscle arterioles.
    Sun D; Messina EJ; Koller A; Wolin MS; Kaley G
    Am J Physiol; 1992 Apr; 262(4 Pt 2):H1211-6. PubMed ID: 1566902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of endothelial nitric oxide biosynthesis by N-nitro-L-arginine.
    Dubbin PN; Zambetis M; Dusting GJ
    Clin Exp Pharmacol Physiol; 1990 Apr; 17(4):281-6. PubMed ID: 2347118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.